Mesenchymal stem cell-derived conditioned medium demonstrates novel antibacterial effects in ocular bacterial infections.
Abbireddy S., Joseph J., Bagga B., Shukla S.
Laboratory Study on Immune Modulation, published in Infect Immun (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Infect Immun (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42060691
- DOI
- 10.1128/iai.00697-25
Abstract (original English)
Bacterial keratitis is a potentially blinding corneal infection, with Staphylococcus aureus and Pseudomonas aeruginosa being the leading gram-positive and gram-negative pathogens, respectively. The increasing antimicrobial resistance among these pathogens necessitates the development of newer therapeutic approaches. This study aims to assess the therapeutic efficacy of mesenchymal stem cell-derived conditioned medium (MSC-CM) for ocular isolates of S. aureus and P. aeruginosa . The MSCs were derived from human adipose tissue, bone marrow, dental pulp, and umbilical cord. The antibacterial effects of MSC-CM were studied through zone of inhibition and colony-forming unit assays, whereas morphological changes were studied through scanning electron microscopy. Furthermore, to mimic bacterial infections, human corneal epithelial cells were stimulated with bacterial endotoxins, and changes in the expression of antimicrobial peptides (LL-37, Human Beta Defensin-3 [HBD-3], Dermcidin, Hepcidin-25, and Lipocalin-2) and inflammatory mediators (IL-6 and TNF-α) were evaluated through enzyme-linked immunosorbent assay. While HBD-3 was present in the highest concentration across all sources of MSCs, treatment with MSC-CM further upregulated the expression of antimicrobial peptides while downregulating the expression of pro-inflammatory mediators, suggesting its immunomodulatory effects. The r
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol